As of Jul 27
| +0.35 / +3.44%|
The 1 analysts offering 12-month price forecasts for SciClone Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 7.50 and a low estimate of 7.50. The median estimate represents a -28.64% decrease from the last price of 10.51.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.